chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sl stiff neck starting on 26NOV95;27NOV95 neck is painful cannot sleep;no h/a, sore throat, fever or other sx;
Before the shot the patient verbally stated and wrote down that he had no history of serious reactions to a vaccine. Administered J&J vaccine and had patient sit on bench for observation for 15 minutes. Within 1 minute of administration he fell over to his right, rolled on the ground, hit his head and was unconscious for 10 seconds. I rushed over and kept him on his side and held his head stable so he wouldn't hit it again as he was stiffening up. After he came to we helped him back up to the bench and gave him water. The color in his face returned shortly after and he insisted he was ok. He then admitted that he had a similar experience to a TB test but denied having a history of seizures. Patient refused us to take his blood pressure or take a glucose tab and persisted that he was ok. He left on his own power after statements were taken by management.
Temp to 106; evening p/receiving inject-duration 24hrs elevated temp; tx w/Tylenol & sponge bath.
I began feeling a migraine at 3pm. I took a nap and woke up at 6pm feeling extremely ill. My temperature was 101.5F and my entire body was in pain. I took two Tylenol as suggested. Over the course of the entire evening, I was vomiting profusely; I vomited approximately 10 times. By around 10pm my extremities became numb and I could not walk without assistance. I could not think or speak straight. I nearly fainted every time I tried to sit up. I tried to take ondansetron for vomiting but proceeded to vomit the medication as well. I wanted to go in to the ER because I felt like I was dying, but I do not feel financially comfortable doing so. All symptoms remained consistent until about 3am when I was able to sleep until 7am. I woke up with several bouts of diarrhea, intense nausea, and head to toe muscle and joint pains, as well as numbness and tingling in my arms and legs still. It is now 5pm the next day and I still can't eat or stand for too long without feeling faint. I still have diarrhea and strong migraine.
Case fully vaccinated with one dose of Janseen vaccine on 3/10/2021. Tested positive for COVID on 8/18/2021. Case was admitted to hospital on 8/22/2021 and expired on 9/24/2021 while still hospitalized.
had myalgias and malaise on post-vaccination day 1.  Had significant erythema and swelling at injection site and lymphadenopathy on post-vaccination day 6.
Flu-like symptoms; This spontaneous case was reported by a patient and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms) outcome was unknown.            No concomitant products were reported by the reporter. No treatment medication provided by the reporter.  The patient wore an ring that measures the readiness to face the day and mentioned that the score after the  second Moderna shot was 29 and it was bad.
This spontaneous report as received from a nurse refers to an unspecified number of patients. On unknown dates the patients were vaccinated with improperly stored ROTATEQ (lot #, expiration date, dose unspecified). No adverse symptoms reported. The temperature excursion for ROTATEQ was found to be supported with in-house stability data. This is one of several reports received from same source. Additional information has been requested.
Information has been received from a office manager concerning a 30 month old female who was vaccinated with the first dose of VARIVAX (Merck) at their one year visit.  The patient just visited the office now 30 months old and has developed shingles.  At the time of the report it was unknown if the patient had recovered from shingles.  Unspecified medical attention was sought.  Additional information has been requested.
second dose of Daptacel administered after 2 days of first vaccination; small erythematous papules all over her body, but not on the injection it was itching.; small erythematous papules all over her body, but not on the injection which did not itch; Initial information received on 15-Aug-2019 regarding an unsolicited valid non-serious case received from a nurse.  This case involves a 14 months old patient who experienced small erythematous papules all over her body, but not on the injection which did not itch, small erythematous papules all over her body, but not on the injection it was itching while received vaccine DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HIB VACCINE (HIB) and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR).  On 16-Apr-2019, the patient received a first dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE lot C5307AA via intramuscular route in unknown administration site and on 18-Apr-2019 also received a second dose of the same vaccine lot C5523AA.  On 16-Apr-2019, the patient developed a non-serious small erythematous papules all over her body, but not on the injection which did not itch (rash erythematous) six hours following the administration of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE.  18-Apr-2019, the patient developed a non-serious small erythematous papules all over her body, it was itching (rash pruritic) two days following the administration of DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE.  It was also case of actual medication error due to inappropriate schedule of vaccine administered second dose of Daptacel administered after 2 days of first vaccination.  (Other relevant tests included no lab data.) Final diagnosis was Erythematous rash and Itchy rash.  The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]).  The patient outcome is reported as Unknown for erythematous rash and Itchy rash.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.  List of documents held by sender: none.
patient her second Moderna COVID 19 shot on 8/16/21 at 3pm, and by 3am on 8/17/21 she had high fever and severe vertigo. She was unable to walk, stand. She has never had vertigo before in the past. She missed multiple days of work because she was too vertiginous to work. She also had headache. her migraine medication rizatriptan helped with headache, but did not help with vertigo. AS of her last ENT office visit she still had vertigo, still unable to drive, but was getting a little better. Physical exam ruled out BPPV and the rest of the vestibular physical exam did not localize to any peripheral vestibulopathy. history and physical consistent with central vertigo that I clinically believe was secondary to her second covid19 shot.  By a week after this shot she was still too vertiginous to drive. I do not know how long this disability due to vertigo will last. I will continue to follow her.
Information has been received from a pharmacist concerning a 62 year old female with no reported medical history who on 21-OCT-2011 received a dose of ZOSTAVAX subcutaneously. Concomitant medications included EVISTA. On an unspecified date, the patient developed a mild case of shingles after she received a dose of ZOSTAVAX. The patient sought medical attention and was treated with valacyclovir. No diagnostic test were performed. At the time of reporting, it is unknown if the patient has recovered. No other information is available. Additional information has been requested.
ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 12/17/2021 CEREBRAL EMBOLISM ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 12/17/2021 STOMACH CANCER, PYLORIC ANTRUM ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 12/17/2021 HEADACHE
Around 0855 patient was seen in passenger seat with family member. Patient was made aware she was about to receive her second dose of Pfizer vaccine, acknowledged nurse affirmatively, gave consent and vaccine administered. Upon returning patient card to staff to add second dose, patient was noted to have received a first dose of Moderna vaccine on 4/14/21 and scheduled to receive second dose of Moderna on 5/12/21. Patient was assessed for allergic reaction, no redness, hives, swelling, itching, S.O.B. were noted. Patient remained comfortable in car, denying any pain or discomfort. Vital signs were assessed BP 170/87 HR 78 R 18 Temp 97.7F Patient stated, "I'm feeling okay, I didn't take my blood pressure medications  this morning because I was coming to get the Covid shot." Patient was seen by medical provider inside of the clinic. Patient returned to Covid tent to pick up vaccination card in stable condition and encouraged to verbalize all concerns with her healthcare provider at anytime.
She developed extreme on her arm, in the same evening, she developed numbness and extreme pain suffered for 2 days.
Patient reports progressively swelling of the tonsillar tissue, with mild to moderate tenderness. Per patient, the swelling and tenderness has persisted since the vaccination with no improvement. On physical exam, there is tenderness and submandibular swelling of approx 4-5 cm
Mother called this facility 4/11/05 to report her child had seen physician and was diagnosed with the chicken pox.  Has had no fever.  Onset 4/6/05.  50-259 lesions.
Pt exp fever 2.5 days duration; red, swollen arm @ site; pain, redness, inflammation conjunctiva-bilateral worse in rt; rx w/DPH & cold compresses & Pred eye gtts;
The first adverse event after my vaccine occurred on the morning of 4/24/2021. This was my first period that I had following my first vaccine dose. When I woke up, I was brushing my teeth and felt a huge gush of what I thought was blood come out from my vagina. I went to the bathroom and saw the biggest blood clot I had ever seen in my life. I was so alarmed by it that I took a picture and told my husband that I thought I was going to die! I didn't know why I had such a huge blood clot. The blood clots are as long as and sometimes bigger than the length of my entire pointer finger down to my thumb.   Since then, I have had one huge blood clot every month when I get my period. I have taken pictures of each one because I was so alarmed by the size of them. I have had small blood clots during my period in the past but these blood clots since I've had my Moderna Covid vaccine are so massive in comparison to anything I've even had in my life.
Immediately with administration, fainted in chair. (-) fall. lasted 3-5 seconds.
an extra dose of ADACEL was administered to a patient with no ae; Initial information received on 17-Feb-2022 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 60 years old female patient who experienced an extra dose of adacel was administered to a patient with no ae while receiving vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 14-Jan-2022, the patient received a first  dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE lot U7055BA,ED : 03-06-2023  via intramuscular route with left deltoid administration site.   On 17-Feb-2022 she also received a  second dose of the same vaccine  lot U7055BA,ED : 03-06-2023 via intramuscular route with left deltoid administration site and patient developed a non-serious event "an extra dose of adacel was administered to a patient with no adverse event" (extra dose administered) 1 month 3 days following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Action taken with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL) was not applicable.  It was not reported if the patient received a corrective treatment for the event (an extra dose of ADACEL was administered to a patient with no ae).  At time of reporting, the outcome was Unknown for the event an extra dose of adacel was administered to a patient with no ae.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
11 AM received vaccine. 12 PM Pt noticed redness on neck and trunk. 2 PM redness less on neck and trunk.
At 2 am diarrhea, upset stomach, slight arm pain at injection site.  At 3 pm nausea and exhaustion, woken from nap at 10 pm, temperature taken (100.0 degrees Fahrenheit), shooting stomach pains, headache, neck pain and general aches in joints.
Client alerted EMT's and myself at 3:49 PM that she was feeling that her fingertips were tingling, stated "feels like pins and needles." Client was clearly anxious and stated she felt clammy. First vitals were taken on right arm BP 150/96, Pule 104, O2 SAT 99%. I advised patient to remove mask  in order to breathe fully. EMT guided client with breathing techniques to clam her down. Client refused 911 call  and started to calm down.  At 3:58 PM vitals were retaken on right arm and BP 126/86, pulse 86, O2 SAT 99%. Client stated she was feeling better and could drive home alone. At 4:12 final vitals were 122/74, pulse 76, O2 SAT 99%.
Moderna has destroyed my body; headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Moderna has destroyed my body) and HEADACHE (headaches) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Moderna has destroyed my body) and HEADACHE (headaches). At the time of the report, VACCINATION COMPLICATION (Moderna has destroyed my body) and HEADACHE (headaches) outcome was unknown.            No Concomitant medications were reported. No Treatment medications were reported.
pt recv vax 16JUN97 & 26JUN97 pt devel a rash on the chest & upper back & a fever of 101.2;
she is positive that she is positive" and is having symptoms, although not yet been tested; she is positive that she is positive" and is having symptoms, although not yet been tested; This is a spontaneous report from a contactable pharmacist (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reportedly asking if she should keep her appointment for the second dose of the vaccine as scheduled if she thinks she was positive for COVID and having symptoms. The patient had vaccine on Tuesday (Dec2020), and husband tested positive yesterday, "she was positive that she was positive" and was having symptoms, although not yet been tested. The 2nd dose was in 2 weeks. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested.; Sender's Comments: Based on the information currently provided, the company considers that a causal relationship between the suspected COVID-19 and vaccination with BNT162B2 cannot be excluded.
bad cough, h/a, runny nose & eyes for 9 days started 3rd day p/shot;
Patient is a 32 year old G4P3 at 38 weeks & 2 days confirmed by ultrasound for an EDD of 1/26/22. She presented to triage for IOL. Patient reports feeling well, has no complaints.  Pregnancy complicated by HTN. Denies headache, change in vision, loss of fluid, vaginal bleeding, vaginal discharge, swelling, chest pain, shortness of breath, abdominal pain, nausea, vomiting, diarrhea, dysuria, fever/chills. She reports good fetal movement throughout pregnancy. Takes PNV.  PT CONTINUES TO BE INPATIENT.
Hallucinating; This spontaneous case was reported by a consumer and describes the occurrence of HALLUCINATION (Hallucinating) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HALLUCINATION (Hallucinating) (seriousness criterion medically significant). At the time of the report, HALLUCINATION (Hallucinating) outcome was unknown.            No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.  This case concerns a patient of unknown age and gender with no reported medical history who experienced the unexpected event of hallucination. The event occurred on am unknown date relative to the second dose of Moderna COVID-19 Vaccine. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.   This case was linked to MOD-2021-370248 (Patient Link).; Sender's Comments: This case concerns a patient of unknown age and gender with no reported medical history who experienced the unexpected event of hallucination. The event occurred on am unknown date relative to the second dose of Moderna COVID-19 Vaccine. The benefit-risk relationship of Moderna COVID-19 Vaccine is not affected by this report.
No additional AE reported; products that experienced temperature excursion were administered; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 14-JUL-2023, the patient was vaccinated with improperly stored (Product storage error) doses of hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, intramuscular injection, lot # reported and confirmed as: X004813, expiration date reported and confirmed as: 28-JUL-2024; and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin) (M-M-R II) injection, lot # reported and confirmed as: W017556, expiration date reported and confirmed as: 07-JAN-2024 (exact doses, strengths, sites and and routes of administration were not provided) for prophylaxis. Temperature excursion details: occurred on 11-JUL-2023; temperature above 47 degree Fahrenheit (46.7 degree Fahrenheit) for 25 minutes; no previous temperature excursion. No additional adverse event reported.
This is a spontaneous report from a none-clinical study report. A contactable consumer reported that his/her currently 15-year-old daughter received meningococcal group B rlp2086 from an unspecified date to an unspecified date at 1 DF, single, influenza vaccine from an unspecified date to an unspecified date at 1 DF, single. The patient medical history was not reported. The patient have never had a flu shot or  meningitis. The patient's concomitant medications were not reported. The patient got sicker than she had ever been on an unspecified date with outcome of unknown. Narrative as reported: Myself or my daughter (who is now 18) have never had a flu shot or meningitis, my daughter got both vaccines this year and have gotten sicker than she had ever been. No follow-up attempts possible. No further information provided.
Rashes appeared on various part of the body starting Saturday morning. Gradually spread to other parts while subsiding in others. Rashes caused mild itch.  Took a bath with bicarbonate soda and oatmeal.  Rashes had mostly cleared by next morning and completely cleared by Monday.
chronic eosinophilic pneumonia; This spontaneous case was reported by a physician and describes the occurrence of EOSINOPHILIC PNEUMONIA CHRONIC (chronic eosinophilic pneumonia) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EOSINOPHILIC PNEUMONIA CHRONIC (chronic eosinophilic pneumonia) (seriousness criterion medically significant). At the time of the report, EOSINOPHILIC PNEUMONIA CHRONIC (chronic eosinophilic pneumonia) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment information was provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown),  was not applicable.  Patient was diagnosed with the condition three weeks after the second dose of the vaccine. This case concerns a 61 year old male with no reported medical history , who experienced Serious , Unexpected event of Eosinophilic Pneumonia. This event  3 weeks after vaccination with the 2nd dose of mRNA-1273 vaccine (Moderna Covid 19 vaccine ) . The re-challenge for this case is not applicable since the event occurred after the 2nd dose and no additional doses will be given. The benefit -risk relationship of mRNA-1273 vaccine (Moderna Covid 19 Vaccine ) is not affected by this report.; Sender's Comments: This case concerns a 61 year old male with no reported medical history , who experienced Serious , Unexpected event of Eosinophilic Pneumonia. This event  3 weeks after vaccination with the 2nd dose of mRNA-1273 vaccine (Moderna Covid 19 vaccine ) . The re-challenge for this case is not applicable since the event occurred after the 2nd dose and no additional doses will be given. The benefit -risk relationship of mRNA-1273 vaccine (Moderna Covid 19 Vaccine ) is not affected by this report.
redness & swelling @ inject site followed by fever inc swelling & blisters @ inject site; seen in ER;
His mother said 3 days following his first dose of the Rota vaccine he had the following symptoms: runny nose, diarrhea, and low grade fever of 100.4. Earlier this week he received his second Rota vaccine and now three days later he has a low grade fever (100.1 F), projectile diarrhea, and runny nose and just irritable and cranky.
Starting the following day after receiving the vaccine, I woke up fatigued and was having body aches. I felt a little feverish/chills which didn't last all day. The fatigue persisted and I ended up sleeping the rest of the day. By the next day, I was totally fine.
Bruising at around insertion point and a growth has appeared between my right arm pit and pectorales major.
On day 9 after first dose of Moderna COVID vaccine, patient developed a circle around injection site that she describes as red, slightly itchy. States it faded after 2-3 days without treatment.